GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bavarian Nordic AS (WBO:BAVA) » Definitions » Institutional Ownership

Bavarian Nordic AS (WBO:BAVA) Institutional Ownership : 20.00% (As of Dec. 14, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Bavarian Nordic AS Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Bavarian Nordic AS's institutional ownership is 20.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Bavarian Nordic AS's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Bavarian Nordic AS's Float Percentage Of Total Shares Outstanding is 0.00%.


Bavarian Nordic AS Institutional Ownership Historical Data

The historical data trend for Bavarian Nordic AS's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bavarian Nordic AS Institutional Ownership Chart

Bavarian Nordic AS Historical Data

The historical data trend for Bavarian Nordic AS can be seen below:

2024-02-29 2024-03-31 2024-04-30 2024-05-31 2024-06-30 2024-07-31 2024-08-31 2024-09-30 2024-10-31 2024-11-30
Institutional Ownership 16.94 17.01 17.57 18.03 18.00 18.49 18.90 19.35 19.53 20.00

Bavarian Nordic AS Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Bavarian Nordic AS Business Description

Address
Philip Heymans Alle 3, Hellerup, DNK, DK-2900
Bavarian Nordic AS is a biotechnology company focused on the research, development, manufacturing, and commercialization of life-saving vaccines. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets. Its products include Encepur, Jynneos, Rabipur, Vaxchora and Vivotif.

Bavarian Nordic AS Headlines

No Headlines